Back to Search Start Over

Supplementary Figure 2 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....9a2baadc40b5ffea0f52ba57737a2346
Full Text :
https://doi.org/10.1158/1078-0432.22463172